Sign in

You're signed outSign in or to get full access.

Brian S. Olschan

President and Chief Operating Officer at ACME UNITED
Executive
Board

About Brian S. Olschan

Brian S. Olschan (age 68) is President and Chief Operating Officer of Acme United Corporation and has served as a director since 2000. He has been COO since January 1999 and President since January 2007, following earlier roles in sales and marketing; prior external experience includes General Cable Corporation where he was Vice President and General Manager of its Cordset and Assembly Business . Company performance context: net income rose from $3.0 million in 2022 to $8.1 million in 2023 (excluding a $9.6 million gain) and $10.0 million in 2024, while the Company’s TSR index on a $100 initial investment moved from 67 in 2022 to 131 in 2023 and 116 in 2024 .

Past Roles

OrganizationRoleYearsStrategic Impact
Acme United (ACU)Senior Vice President – Sales & MarketingSep 1996–Jan 1999Built operational knowledge across sales/marketing, foundation for later COO role
Acme United (ACU)Executive Vice President & Chief Operating OfficerJan 1999–Dec 2006Led operations; detailed knowledge of Company’s operations
Acme United (ACU)President & Chief Operating OfficerJan 2007–PresentOversees company operations; multi-decade leadership continuity

External Roles

OrganizationRoleYearsStrategic Impact
General Cable CorporationVice President & General Manager, Cordset and Assembly BusinessN/AElectrical wire/cable manufacturing leadership experience

Fixed Compensation

Metric20232024
Base Salary ($)$838,597 $888,903
All Other Compensation ($)$11,887 $12,887

Notes: All Other Compensation includes life insurance premium reimbursement and Company matching contribution to the 401(k) plan . Acme’s 401(k) plan match is 50% of the first 6% of eligible compensation, subject to IRS limits; executives participate on the same basis as other employees .

Performance Compensation

Cash Bonus (structure and payouts)

Item20232024
Bonus Plan MechanicsCash bonus pool generally set at 15% of budgeted net income before taxes; adjusted to 14–16% based on performance; individual allocations typically 0–25% of base salary, subject to total accrual cap Same program structure
Plan-based Bonus AwardedNo plan-based bonuses awarded; transaction-based bonuses paid (Camillus/Cuda disposition) No plan-based bonuses awarded; transaction-based bonuses paid
Actual Bonus Paid to Olschan ($)$435,588 $130,670
Deferred Compensation ProgramExecutives may irrevocably elect to defer a portion/all of next year’s Cash Bonus; deferred amounts earn Prime+1% compounded quarterly; Company adds 20% up to $10,000/year; amounts paid at separation Same

Equity Awards (options)

Grant/Feature20232024
Option Awards ($ fair value)$253,000 — (no options granted)
2023 Option Grant Size (shares)20,000 N/A
2023 Option Exercise Price$30.47 per share N/A
Vesting ScheduleOptions vest in four equal annual installments starting one day after first anniversary, then annually for three years; 10-year term N/A

Performance Metrics & Payout Mechanics

MetricWeighting/MechanicsTargetActualPayoutVesting
Budgeted net income before taxes (Company-wide)Bonus pool equals 15% of budgeted NIBT; adjusts to 14% at 90% of budget and 16% at 110%; individual awards typically 0–25% of base salary Annual budget set by Compensation Committee 2023–2024 bonuses were transaction-based (asset disposition); no plan-based bonus paid $435,588 (2023), $130,670 (2024) cash to Olschan Cash; deferred compensation available per plan
Long-term equity (stock options)Performance-based stock option awards in program; vest over 4 years; 10-year term Grant approvals per committee discretion2023: 20,000 options @ $30.47; 2024: none Fair value $253,000 (2023); 2024 none Options vesting per schedule

Equity Ownership & Alignment

ItemData
Beneficial Ownership (shares)286,553
Percent of Class7.2% (based on 3,754,498 shares outstanding as of March 5, 2025)
Shares Included via Options (within 60 days)245,450
Ownership NatureSole voting and investment power except as noted in proxy footnotes
Hedging PolicyCompany “has not adopted any practices or procedures regarding the ability” of employees or directors to engage in hedging transactions that offset declines in ACU securities

Outstanding Equity Awards (as of Dec 31, 2024)

Exercisable (#)Unexercisable (#)Exercise Price ($)Expiration Date
45,00023.991/24/27
35,00024.9210/16/27
9,20023.941/23/28
35,00022.668/8/28
20,00019.488/7/29
7,50024.061/21/30
35,00023.058/12/30
11,2503,75032.641/26/31
26,2508,75039.568/11/31
12,50012,50029.358/3/32
5,00015,00030.478/2/33

Employment Terms

Change-in-Control (CIC) Plan

FeatureTerms
Cash CompensationMonthly salary at rate on CIC date multiplied by months payable; plus average monthly incentive bonuses for the three taxable years immediately prior to CIC multiplied by months payable
Benefits ContinuationMedical, life and other insurance continue for the number of months compensation is payable
CIC Multiple (Director who is EVP or above)36 months compensation and benefits (applies to Messrs. Johnsen and Olschan)
280G CutbackPayments reduced to avoid “excess parachute payment,” capped at 2.99× base amount
Payment TimingLump sum within 30 days after separation; 6-month delay for “key employees”

Severance Pay Plan (if CIC Plan not applicable)

FeatureTerms
TriggersInvoluntary termination (other than gross misconduct); death; reduction of responsibility/status/compensation; transfer to unreasonably distant location
FormulaOne month’s salary × years of service; subject to min/max months based on level
Director who is EVP or aboveMinimum 9 months; maximum 30 months compensation; death benefit equals 9 months

Board Governance and Committee Roles

  • Board service: Olschan is a non-independent director (employee) standing for re-election; the Board determined that six other directors are independent under NYSE American rules .
  • Board structure: ACU combines Chairman and CEO positions; there is no Lead Independent Director; Board held seven meetings in 2024 and all directors attended at least 75% of meetings of the Board and committees on which they served .
  • Committees: Executive, Audit, Compensation, and Nominating Committees are composed solely of independent non-employee directors; committee memberships are listed and do not include Olschan .
  • Independence implications: Dual-role senior executives (CEO and President/COO) serving as directors are classified as non-independent; combined Chair/CEO without a lead independent director may be a governance consideration for investors .

Performance & Track Record

Metric202220232024
Net Income ($000s)$3,037 $8,148 (excludes $9.6m gain) $10,022
TSR Index (Value of Initial $100 Investment)67 131 116
Business MilestonesAsset disposition of Camillus & Cuda (Nov 1, 2023) Elite First Aid asset acquisition integrated; diversification to ~61% first aid/medical; ~$2m annual savings from cost reductions; DC capacity +30%

Equity Compensation Plan Information (context)

ItemData
Securities to be issued upon exercise of outstanding options/warrants/rights1,403,090
Weighted-average exercise price$27.82
Securities available for future issuance under equity plans223,875

Related Party Transactions and Policies

  • Policy: Related person transactions must be reviewed/approved by the Audit Committee (independent directors only); ongoing monitoring required .
  • Transactions: None since January 1, 2023 .
  • Insider Trading Policy: Long-standing policy exists (see 10-K exhibit); Company has not adopted practices/procedures regarding the ability of employees/directors to hedge ACU securities .

Investment Implications

  • Alignment: Olschan’s 7.2% beneficial ownership, including 245,450 options exercisable within 60 days, signals high alignment with shareholders; sustained net income growth under his operational leadership supports pay-for-performance narratives .
  • Incentive mix and selling pressure: Significant outstanding options with staggered expirations through 2033 and multiple exercise prices could create periodic liquidity/selling pressure when tranches vest/become in-the-money; 2023 option grant of 20,000 at $30.47 adds to near- to medium-term optionality .
  • Bonus quality: 2023–2024 executive bonuses were transaction-based (asset disposition), not tied to plan-based operating targets; future cash incentive visibility hinges on achieving budgeted net income thresholds per the bonus plan .
  • Governance risk: Combined Chair/CEO and absence of a lead independent director, plus Olschan’s non-independent director status as President/COO, reduce counterweights to management; investors often discount governance structures with limited independent leadership .
  • Retention economics: CIC plan (36 months for EVP+ directors) and severance plan (up to 30 months) provide strong retention but elevate change-of-control costs; 280G cutback mitigates tax gross-up risk and caps parachute payments .
  • Hedging policy gap: The Company reports no adopted practices/procedures restricting hedging by employees/directors; investors may view this as a potential misalignment risk if hedging occurs, as it can weaken exposure to downside .
  • Clean related-party profile: No related person transactions since 2023; committee oversight structure is in place, reducing conflict-of-interest risk .